344 related articles for article (PubMed ID: 18037508)
1. Cysteine cathepsin proteases as pharmacological targets in cancer.
Palermo C; Joyce JA
Trends Pharmacol Sci; 2008 Jan; 29(1):22-8. PubMed ID: 18037508
[TBL] [Abstract][Full Text] [Related]
2. Cathepsins and pancreatic cancer: the 2012 update.
Sulpizio S; Franceschini N; Piattelli A; Di Sebastiano P; Innocenti P; Selvaggi F
Pancreatology; 2012; 12(5):395-401. PubMed ID: 23127526
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cysteine cathepsin protease activity enhances chemotherapy regimens by decreasing tumor growth and invasiveness in a mouse model of multistage cancer.
Bell-McGuinn KM; Garfall AL; Bogyo M; Hanahan D; Joyce JA
Cancer Res; 2007 Aug; 67(15):7378-85. PubMed ID: 17671208
[TBL] [Abstract][Full Text] [Related]
4. Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.
Olson OC; Joyce JA
Nat Rev Cancer; 2015 Dec; 15(12):712-29. PubMed ID: 26597527
[TBL] [Abstract][Full Text] [Related]
5. The cathepsin family and their role in colorectal cancer.
Kuester D; Lippert H; Roessner A; Krueger S
Pathol Res Pract; 2008; 204(7):491-500. PubMed ID: 18573619
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of proteases as anticancer drugs.
Jedinak A; Maliar T
Neoplasma; 2005; 52(3):185-92. PubMed ID: 15875078
[TBL] [Abstract][Full Text] [Related]
7. The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics.
Yasuda Y; Kaleta J; Brömme D
Adv Drug Deliv Rev; 2005 May; 57(7):973-93. PubMed ID: 15876399
[TBL] [Abstract][Full Text] [Related]
8. Cysteine cathepsins: multifunctional enzymes in cancer.
Mohamed MM; Sloane BF
Nat Rev Cancer; 2006 Oct; 6(10):764-75. PubMed ID: 16990854
[TBL] [Abstract][Full Text] [Related]
9. Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases.
Premzl A; Puizdar V; Zavasnik-Bergant V; Kopitar-Jerala N; Lah TT; Katunuma N; Sloane BF; Turk V; Kos J
Biol Chem; 2001 May; 382(5):853-7. PubMed ID: 11517941
[TBL] [Abstract][Full Text] [Related]
10. Cysteine proteinases in cancer progression and their clinical relevance for prognosis.
Lah TT; Kos J
Biol Chem; 1998 Feb; 379(2):125-30. PubMed ID: 9524063
[TBL] [Abstract][Full Text] [Related]
11. The proteasome: a new target for novel drug therapies.
Elliott PJ; Ross JS
Am J Clin Pathol; 2001 Nov; 116(5):637-46. PubMed ID: 11710679
[TBL] [Abstract][Full Text] [Related]
12. Biochemical properties and regulation of cathepsin K activity.
Lecaille F; Brömme D; Lalmanach G
Biochimie; 2008 Feb; 90(2):208-26. PubMed ID: 17935853
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal cysteine proteases: structure, function and inhibition of cathepsins.
Roberts R
Drug News Perspect; 2005 Dec; 18(10):605-14. PubMed ID: 16491162
[TBL] [Abstract][Full Text] [Related]
14. The current stage of cathepsin B inhibitors as potential anticancer agents.
Kos J; Mitrović A; Mirković B
Future Med Chem; 2014 Jul; 6(11):1355-71. PubMed ID: 25163003
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the cathepsin cysteine proteases B and K by square-planar cycloaurated gold(III) compounds and investigation of their anti-cancer activity.
Zhu Y; Cameron BR; Mosi R; Anastassov V; Cox J; Qin L; Santucci Z; Metz M; Skerlj RT; Fricker SP
J Inorg Biochem; 2011 May; 105(5):754-62. PubMed ID: 21481817
[TBL] [Abstract][Full Text] [Related]
16. Role of lysosomal cathepsins in naphthazarin- and Fas-induced apoptosis in oral squamous cell carcinoma cells.
Johansson AC; Norberg-Spaak L; Roberg K
Acta Otolaryngol; 2006 Jan; 126(1):70-81. PubMed ID: 16308258
[TBL] [Abstract][Full Text] [Related]
17. Dual contrasting roles of cysteine cathepsins in cancer progression: apoptosis versus tumour invasion.
Vasiljeva O; Turk B
Biochimie; 2008 Feb; 90(2):380-6. PubMed ID: 17991442
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin K inhibitors: a novel target for osteoporosis therapy.
Stoch SA; Wagner JA
Clin Pharmacol Ther; 2008 Jan; 83(1):172-6. PubMed ID: 18073778
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell proliferation and cathepsin inhibition in gastric cancer.
Choi EH; Kim JT; Kim JH; Kim SY; Song EY; Kim JW; Kim SY; Yeom YI; Kim IH; Lee HG
Clin Chim Acta; 2009 Aug; 406(1-2):45-51. PubMed ID: 19463800
[TBL] [Abstract][Full Text] [Related]
20. Antibody-mediated inhibition of cathepsin S blocks colorectal tumor invasion and angiogenesis.
Burden RE; Gormley JA; Jaquin TJ; Small DM; Quinn DJ; Hegarty SM; Ward C; Walker B; Johnston JA; Olwill SA; Scott CJ
Clin Cancer Res; 2009 Oct; 15(19):6042-51. PubMed ID: 19789302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
